In-space manufacturing on episode 7 of ISS nationwide Lab podcast

In the most recent episode of Between a Rocket & a Hard Space, the official podcast of the ISS National Lab, we discover the slicing fringe of in-space manufacturing with two visionary leaders pushing the boundaries of biomedical innovation onboard the area station.

We’re joined by Yupeng Chen of the University of Connecticut and Mari Anne Snow, CEO of Eascra Biotech. The pair talk about their collaborative efforts to develop nanomaterials in microgravity that would someday revolutionize therapies for ailments starting from most cancers to osteoarthritis.

Over the previous two years, their groups have carried out 5 investigations on the area station. Leveraging the distinctive situations in low Earth orbit, the researchers confirmed that in-space manufacturing considerably improves the construction of the nanomaterials, which results in higher affected person outcomes. These experiments are laying the groundwork for future therapies that would enhance high quality of life for tens of millions.

We dive into the early origins of their work, the challenges and worth of conducting biomedical analysis in area, and what in-space manufacturing may seem like on future business area platforms.

Be positive to tune into the most recent episode of Between a Rocket & Hard Space to find out how ISS analysis is benefiting humanity and driving a sturdy and sustainable economic system in low Earth orbit.